The Dividend Harvesting Portfolio achieved a 45.8% return on investment, generating $3,289.51 in annual dividends from a $28,800 investment, with a yield of 7.83%. Recent portfolio additions include Pfizer, valued for its yield above 6% and low earnings multiple, and AGNC Investment, offering a 13.52% yield amid rising rates. The strategy focuses on compounding dividend income through reinvestment and growth, with plans to streamline ETFs and CEFs for better sector balance and position allocation. This approach aims to build sustainable, growing monthly dividend income for long-term financial security.
Pfizer shares trade at $28.77 with a 5.91% dividend yield and a 12-month price target of $32.72, implying 13.84% upside. The company reported strong Q2 2026 results, raised revenue guidance, and has a promising pipeline including Padcev and Metsera o...
Pfizer's stock has declined nearly 20% over five years, pushing its dividend yield to around 6%. Despite this, the company continues to pay a steady $0.43 quarterly dividend, supported by earnings that cover the payout but with tight cash flow margin...
